Page 83 - ASME_NEMB_2016_Program
P. 83

TRACK 6                                                 TRACK 6                      Technical Program




        We hypothesize that the large excess of non-aggregated GNPs (thus back-  4. Philippar, U., et al. Developmental Cell, 2008. 15(6): p. 813-28.
        ground) for higher probe concentration explains the less sensitive detection.   5. Hernandez, L., et al. Cancer Research, 2009. 69(7): p. 3221-7.
        Increasing the GNP size (from 15nm to 50nm) improves the sensitivity as   6. Mosadegh, B., et al. Biotechnol Bioeng, 2008. 100(6): p. 1205-13.
        well as peak shift (thus signal) by up to 3-fold. Current sensitivity is similar to   7. Saadi, W., et al. Biomedical Microdevices, 2006. 8(2): p. 109-118.
        lateral flow assay and future work is needed to improve sensitivity. Our work   8. Wang, S.J., et al. Exp Cell Res, 2004. 300(1): p. 180-9.
        presents guidelines to rationally design this nanoparticle assay for better   9. Yamada, K.M. and E. Cukierman. Cell, 2007. 130(4): p. 601-610.
        sensitivity and signal strength.                        10. Griffith, L.G. and M.A. Swartz. Nat Rev Mol Cell Biol, 2006. 7(3): p. 211-24.
                                                                11. Abhyankar, V.V., et al., Lab on a Chip, 2008. 8(9): p. 1507-15.
                                                                12. Haessler, U., et al., Biomedical Microdevices, 2009. 11(4): p. 827-35.
        Development of a Microfluidic Device with Dual Channels for   13. Polacheck, W.J. et al. Proceedings of the National Academy of Sciences
        Growth Factor Gradient on Breast Cancer Chemotaxis in Three   of the United States of America, 2011. 108(27): p. 11115-11120.
        Dimensions
                                                                Utilization of a 3D In Vitro Tumor Platform to Study Nanoparticle
        Poster Presentation. NEMB2016-6107
                                                                Transport
        Alican Ozkan, The University of Texas at Austin, Austin, TX, United   Poster Presentation. NEMB2016-6111
        States, M Nichole Rylander, Univeristy of Texas at Austin, Austin,
        TX, United States
                                                                Kameel Isaac, The University of Texas at Austin, Austin, TX, United
        An important factor in tumor development and metastatic potential is directed   States, M Nichole Rylander, Univeristy of Texas at Austin, Austin,
        migration of cancerous cells. Spatial and temporal gradients intrinsic to the   TX, United States
        tumor microenvironment, significantly mediates migration. Current research
        suggests that the altered tumor microenvironment may drive cancer aggres-  Cancer is a major health problem worldwide, accounting for one in 4
        sion and metastatic potential [1]. Steep growth factor gradients in tumor mi-  deaths in the United States alone. Significant progress in nanomedicine has
        croenvironment, result from the combined effects of high interstitial fluid pres-  been made in order to develop therapies for cancer, particularly related to
        sure, dense extracellular matrix (ECM), and poor perfusion [2, 3]. It has been   enhanced photothermal and photochemical treatments. These nanotech-
        hypothesized that tumor motility and aggressive migration may be caused in   nology-based cancer treatments have the potential to provide localized,
        part by chemotaxis in response to these gradients [1]. In particular, breast tu-  targeted therapies to enhance efficacy and reduce side effects, thereby im-
        mor cells are susceptible to gradients in epidermal growth factor (EGF) due to   proving patients’ quality of life. Understanding the distribution and transport
        overexpression of EGF receptors and related proteins and receptors [4,5].  of nanoparticles (NPs) in the tissue as a function of physiological conditions
                                                                (e.g. matrix properties and hemodynamics) and nanoparticle dimensionality
        With recent advances in tissue engineering, microfluidic techniques and   is critical to optimizing particle design for maximizing delivery and efficacy.
        fabrication, using soft lithography-based two-dimensional polydimethylsilox-  Most commonly, 2D in vitro cell cultures have been used to study NPs and
        ane (PDMS) perfusion chambers, of in vitro tissue microenvironments. Some   their interaction with tumor cells, but do not capture the essential features
        studies have been performed investigating the effect of EGF concentration   of the tumor microenvironment including matrix mechanics, hemodynamics,
        on chemotaxis [6, 7]. Additionally, other studies investigated how the shape   and the elevated interstitial pressure. In vivo models have been used and
        of EGF gradients (linear or nonlinear polynomial) and the magnitude regulate   do capture the tumor microenvironment, but they can be highly variable and
        chemotaxis of MDA-MB-231 metastatic human breast cancer cells [8].   a large number of animals are needed making them cost prohibitive for NP
        Although, these studies are insightful, the complex mechanical, chemical,   optimization. 3D in vitro platforms however are capable of characterizing the
        and perfusion components of the tumor microenvironment have not yet   transport and efficacy of NPs as well as facilitating cell attachment, prolifer-
        been successfully recapitulated. Previous studies have focused on un-  ation, and infiltration, reducing the expense associated with in vivo models
        derstanding specific biological cues rather than improving the fidelity of   and inaccuracy of 2D in vitro models.
        the microenvironment platform. Experiments performed on 2D substrates,
        even those treated with extracellular matrix proteins such as collagen or   In this study, a 3D microchannel system was employed previously devel-
        fibronectin, are unable to provide the three-dimensional microenvironment   oped by the Rylander lab. This 3D in vitro model contains a vascularized
        which has been repeatedly shown to have a momentous effect on cell   collagen type I tumor microchannel polymerized in FEP tubing. Within the
        morphology, signaling, and migration through mechanical and structural in-  microchannel we created an endothelialized vessel by fitting in a stainless
        teractions [9,10]. Studies in three-dimensional matrices generally lack direct   steel needle capped with PDMS sleeves. After polymerization and removal
        perfusion of the microenvironment [11, 12] and therefore cells are subjected   of the stainless steel needle, the vessel was created and seeded with endo-
        to gradients in all growth factors and nutrients. Furthermore, although the   thelial cells. Previous studies by the Rylander lab have employed the same
        importance of the role of matrix mechanics in tumor aggression has been   3D in vitro microchannel system to study tumor-endothelial signaling and
        noted, previous chemotaxis studies have not considered parameters such   vascular organization as a function of flow through the channel. This channel
        as ECM stiffness [8]. Interactions between microenvironment mechanics and   was able to withstand a range of normal, high and low flow shear stresses
        self-expressed chemical cues have been studied, but still at low cell con-  that are relevant to the tumor microvasculature.
        centrations relative to those found in vivo [13].
                                                                To replicate the tumor vasculature and investigate the vessel properties on
        In this study, we developed a microfluidic tumor platform incorporating a   NP transport, we introduced inflammatory agonists such as thrombin (10 U/
        physiological concentration of MDA-MB-231 cells in a collagen I hydrogel   mL) or histamine (100 M), altering endothelium permeability. To measure ves-
        scaffold with a fully three-dimensional geometry. The device is perfused at   sel permeability, 70 kDa Oregon green-conjugated dextran was perfused
        physiological flow rates using two parallel channels (dual channels) with di-  into the channel and imaged to measure fluorescence intensity over time.
        ameters comparable to microvasculature. We have quantified chemotaxis in   The FEP tubing and the water bath were used to allow refractive matching
        response to EGF gradients of varying magnitude formed by diffusion of EGF   for undistorted imaging. Flow was introduced into the microfluidic chan-
        from one channel into the surrounding hydrogel.         nel with a syringe pump producing wall shear stresses of 1-15 dynes/cm2.
                                                                Nanoparticles of different sizes ranging from 50-100 nm were introduced
        1. Roussos, E.T., J.S. Condeelis, and A. Patsialou. Nature Reviews Cancer,   into the flow of the microchannel and images were acquired using a Zeiss
        2011. 11(8): p. 573-587.                                epifluorescent microscope in the span of 72 hours recorded at 10 minute in-
        2. Minchinton, A.I. and I.F. Tannock. Nature Reviews Cancer, 2006. 6(8): p.   tervals. By imaging the channels, we were able to determine the transport of
        583-592.                                                nanoparticles as a function of time, permeability, and NP dimensionality. Use   83
        3. Whatcott, C.J., et al., P.J. Grippo and H.G. Munshi, Editors. 2012: Trivan-  of our 3D in vitro system enabled investigation of the dynamic nanoparticle
        drum (India).                                           transport within a physiologically relevant system providing fundamental un-
   78   79   80   81   82   83   84   85   86   87   88